Government Demands Guarantees For Doliprane Production In France
Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM
- Product Code
- ILEA003454562
- Registered date
- 2024/10/16 00:00:00
- Credit
- Abaca Press / Kyodo News Images
- Media source
- Nguyen Van Hai-Barbier Jean Pierre/ABACA
- Media size
- 9195 × 6119 pixel
- Resolution
- 300 dpi
- Deployment size
- 3.27(MB)*
- Special instruction
*File size when opened in Photoshop, etc.
